LIBRE LIFE LATEST NEWS

Latest news from key diabetes conference covering the latest in medtech, treatments, research and 'cures'. 

Dexcom's financial filings reveal a warning letter from the FDA regarding processing in 2 of its manufacturing plants.

A new CGM launches this February in the UK.

News that Abbott and Dexcom have agreed not to sue each other for patents relating to their CGM tech for another 10 years. 

Sana Biotechnology announce a significant step in the use of islet cells for T1D treatment that could pave the way to a T1D 'cure'!

How 2 London hospitals are trialling use of AI to detect early signs of type 2 diabetes which could be rolled out across the UK by the NHS.

Insulet win case against EO Flow insulin patch pump design.

News that Sanofi made its largest investment in China with new insulin manufacturing in Beijing.

Abbott announces new manufacturing facility in Ireland to address Libre 3 demand.